Closest vote: 🐶 versus 🐈🤷🏽♂️
Cleanest/unanimous vote: POCUS
Our choices where #BlueRibbonFail is most likely: C3G (Dx over Rx) or Trolls (BKV over CMV)
#NephMadness
The 13th #NephMadness crowned its winner this year: 👑 CAR-T in autoimmune disease
Here are the finals of all the editions! It's said that with time, we get wiser: if you could, would you change any results? For some, the winners are incontestable, but is there any #BlueRibbonFail? 🎀💥
The giantest #BlueRibbonFail
ajkdblog.org/2025/04/08/n...
#Nephmadness
but the BRP panel comments are fun to read. Well played!
www.youtube.com/watch?v=NhSC...
My #NephMadness summary
✨Aiming for my best- managed 🔝 2%
As broadly disputed, not choosing HDF was THE #BlueRibbonFail (not commenting about winner). I guess in my part of the world, we are not facing donors' obesity
🎭 For fun aimed for perfect 0- so close!
www.tourneytopia.com/AJKD/NephMad...
We may be a leeeetle bit biased but MCD was robbed. Solved etiology for 90% of the most common peds GN w implications for targeted therapies, post-Tx recurrence… c’mon #NephMadness #BlueRibbonFail @tobias-b-huber.bsky.social
Agreed! I'm right up there (down there) with you at rank 617 #blueribbonfail
So I guess we know who will win? #CAR-Tsurprise #BlueRibbonFail #NephMadness @ajkd.bsky.social
But you know this #BlueRibbonFail panel revels in their random and capricious ignorant decision making
@toates.bsky.social
#NephMadness
Whoah
The CAR-T cells underdog continues to roll on and over novel therapies for hypertension
ajkdblog.org/2025/04/07/n...
A true #NephMadness #BlueRibbonFail
(But well done @melhoenig.bsky.social and @glombandit.bsky.social !)
@glombandit.bsky.social and Dr. Melanie Hoenig sitting in the lead! No perfect brackets remain.
#Nephmadness I just can’t buy CAR-T and MCD diagnosis as the most important issues for nephrologists in the next 5 years.
I wear my 875 out of 906 as a badge of honor 🎖️ #BlueRibbonFail
just as big a #BlueRibbonFail as from #NephMadness 2019 when US #hypertension guidelines was champion, 👀🙄😂😂😀
just an embarrassing #BlueRibbonFail
The biggest #BlueRibbonFail of #NephMadness is CAR-T. Very cool immunology, perhaps useful in extremely severe autoimmunity, but overall impact on nephrology? Next to nil. Too toxic, too hard to scale.
Dialysis innovation eliminated in the 2nd round of #Nephmadness?
People…we cannot have 500,000 plus people in the US alone on the technology of yesterday’s yesterday.
#blueribbonfail
In a parallel universe of #BlueRibbonPanel, Incremental HD win over HDF and then Tubular Toxins win over Incremental HD.Completely opposite to the crowd's vote. An outrageous series of #BlueRibbonFail . #NephMadness @lauraratcliffe7.bsky.social @nephmadness.bsky.social
Ok #NephMadness, I’ve got a few 🦴 to pick with the Filtered 4.
Novel HTN treatment? How about getting to goal with what we got!
CAR-T? Good for cancer, GN not so much yet.
Toxins over dialysis innovation? SRSLY 🫣
MCD over kidney donation? It’s called MINIMAL change for a reason.
#BlueRibbonFail
Now that I’ve given up on #nephmadness, time to learn something about immunology for #rheummadness
#blueribbonfail ed me once, it couldn’t possibly happen again
Good point. I should have specified “all-cause mortality as primary outcome.”
IV iron v HDF would have been a great matchup.
Instead we’ll get 13 years of #nephmadness without ever having a dialysis winner.
Is dialysis the PAC-12 of nephrology? Do we need to consider relegation?
#blueribbonfail
The filtered 4 drop
Novel drugs survive
CAR-T cells?? #BlueRibbonFail
Tubular Toxins end the silly run of incremental HD
MCD diagnosis
#NephMadness #BracketsBusted
ajkdblog.org/2025/04/04/n...
yea, agreed… we chose Natural Disasters because the #BlueRibbonPanel often has a strong US bias… makes sense given the platform though.
Remember the HUGE #BlueRibbonFail outrage of 2019 when US Htn g/l’s was #NephMadness Champion, 👀😳🙄😱🤦🏼♀️🤷🏼♀️😂
ajkdblog.org/2019/04/08/n...
@glaucomflecken.bsky.social if you need some inspo👆🏻
More to come until April 8- just follow the #nephmadness and #BlueRibbonFail hashtags
ajkdblog.org/2025/03/01/w...
I’m in the @nephroseeker.medsky.social camp here
There is no signal of harm with HDF, there is evidence of benefit (with caveats as outlined)
Why not use it in pts who meet CONVINCE enrollment criteria?
FMC is going to sort out the cost here in the US so no whining about that
#BlueRibbonFail
Fake news. Roger called hemodiafiltration losing a #BlueRibbonFail
But I still dislike iHD and agree it’s another #BlueRibbonFail. Probable that Oates character…
1/ BRP members are not supreme authority: science=science, the evidence=evidence. Still looking for positive trials with incremental HD, no? this is outrageously against any ration. Personal feelings don’t change hard endpoints #BlueRibbonFail
That’s the main argument why not moving on with HDF is a ginormous #BlueRibbonFail